- Report
- November 2023
- 178 Pages
Global
From €4686EUR$4,900USD£4,015GBP
- Report
- October 2023
- 183 Pages
Global
From €4686EUR$4,900USD£4,015GBP
- Report
- January 2024
- 215 Pages
Global
From €7602EUR$7,950USD£6,514GBP
- Report
- November 2023
Global
From €7172EUR$7,500USD£6,146GBP
- Report
- January 2023
- 315 Pages
Global
From €4589EUR$4,799USD£3,932GBP
- Report
- September 2022
- 239 Pages
Global
From €7172EUR$7,500USD£6,146GBP
- Report
- August 2019
- 42 Pages
Global
€2864EUR$2,995USD£2,454GBP
- Book
- October 2020
- 288 Pages
- Book
- September 2023
North America
Lymphocytes are a type of white blood cell that play an important role in the body's immune system. In oncology, lymphocytes are used to treat certain types of cancer, such as leukemia and lymphoma. Lymphocytes can be used to target and destroy cancer cells, as well as to stimulate the body's own immune system to fight the cancer. In addition, lymphocytes can be used to detect and monitor cancer cells in the body.
The lymphocytes market within the context of oncology is a rapidly growing field, with many companies developing new treatments and technologies. Companies such as Kite Pharma, Juno Therapeutics, and Adaptimmune are developing new treatments using engineered T-cells, while companies such as Novartis and Gilead are developing CAR-T therapies. Other companies such as Celgene and Merck are developing new drugs to target cancer cells. Additionally, companies such as Immunocore and Cellectis are developing new technologies to detect and monitor cancer cells. Show Less Read more